TriMas has acquired Intertech Plastics, a solutions provider of complex, precision injection moulded components, expanding its product portfolio and capabilities for applications in the medical end market. Intertech will become part of TriMas Packaging, effective immediately.
Intertech, founded by Noel Ginsburg in 1980, consists of two manufacturing facilities located in Denver, Colorado, which specialise in custom injection moulding with advanced manufacturing capabilities for products used in medical applications, as well as products and assemblies for consumer and industrial applications. Intertech’s medical-related product offering, manufactured in a dedicated ISO 13485 certified facility with a Class 8 controlled environment and MedAccred accreditations, includes tight tolerance components used in vascular access and in vitro diagnostic applications. In a separate facility, Intertech manufactures injection-moulded products for food, wellness, hospitality, and e-commerce logistics applications. Intertech has invested in innovation efforts to commercialise sustainable resin technology, including the use of biopolymers and plant-based resins in specific packaging applications. Intertech previously operated as a private, family-owned company, and generated approximately $32 million in revenue in fiscal year 2021.
Thomas Amato, president and chief executive officer of TriMas, said: “We are excited to announce the addition of Intertech to the TriMas family of businesses. We look forward to supporting Intertech’s management team and leveraging the TriMas Business Model to accelerate the growth of products used in medical and health-related applications. The addition of Intertech, combined with TriMas’ December 2021 acquisition of Omega and our existing presence in pharmaceutical & nutraceutical applications, expands our product offerings into the life sciences market, which we believe has attractive long-term growth characteristics.”
Noel Ginsburg, Intertech’s founder and majority shareholder, added: “We have been pleased to work with and carefully select TriMas, as we transition Intertech into its next phase of development. We look forward to TriMas’ support and investments to enhance Intertech’s growth well into the future.”
TriMas’ acquisition of Intertech represents TriMas’ sixth acquisition in the packaging market since early 2019, and its second with products, injection moulding manufacturing capability and customer approvals in the medical technology end market.
Part of Rapid News Group
© Rapid Life Sciences Ltd. A Rapid News Group Company. All Rights Reserved